International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10416825
Original Article
Modified Pterional Approach for the Management of Infratemporal Fossa Tumors
 ,
 ,
 ,
Published
Dec. 18, 2023
Abstract

Introduction: The pterional approach (fronto–temporo–sphenoidal craniotomy) is the most common procedure used for the exposure of Sylvian fissure,frontal and temporal opercula. The tumors of the floor of middle cranial fossa and infra temporal fossa pose a difficulty in access through this approach. Modification of pterional approach, the transzygomatic access osteotomy is one of the core routes to approach infratemporal region. Transzygomatic osteotomy provides enhanced visualization of infratemporal fossa and floor of the middle cranial fossa. The infratemporal tumors may originate from tissues in the region or extending from surrounding tissues.

Method: A series of 5 tumors were treated by author in which 2 were primary in origin and 3 were extension of tumors from mandible. All the cases were approached through hemicoronaltranszygomatic osteotomy except in one case where rhytidectomy incision was given as the tumor was originating from mandibular angle extending to infratemporal region.

Result: The purpose of this article is to access the surgical outcome of the modified pterional approach for the infra temporal fossa tumors. The surgical exposure created by the modified pterional approach was excellent to individuate the tumor margins in all the cases. The depression created by the zygomatic arch osteotomy is aesthetically and functionally accepted by all the patients. Recurrence was noticed in 1case, following chemotherapy and radiotherapy the patient was deceased.

Conclusion:  The management of infra temporal lesions using the modified pterional approach gave an outcome which was both functional and aesthetically established and merely accepted by the patients.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
2906 Views
200 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved